Suppr超能文献

转移调控:线粒体 DNA 突变粉墨登场。

Regulation of metastasis; mitochondrial DNA mutations have appeared on stage.

机构信息

Graduate School of Life and Environmental Sciences, University of Tsukuba, Tennodai, Tsukuba, Ibaraki, Japan.

出版信息

J Bioenerg Biomembr. 2012 Dec;44(6):639-44. doi: 10.1007/s10863-012-9468-6.

Abstract

It has been controversial whether mtDNA mutations are responsible for tumorigenesis and for the process to develop metastases. To clarify this issue, we established trans-mitochondrial cybrids with mtDNA exchanged between mouse tumor cells that possess high and low metastatic potential. The results revealed that the G13997A mutation in the ND6 gene of mtDNA from highly metastatic tumor cells reversibly controlled development of metastases by overproduction of reactive oxygen species (ROS). The transmitochondrial model mice possessing G13997A mtDNA showed symptoms of impaired glucose tolerability, suggesting that ROS generated mtDNA mutations can regulate not only metastatic potential, but also age-associated disorders such as diabetes. We also identified other mtDNA mutations that affect metastatic potential but the mechanisms are independent of ROS production. The mtDNA-mediated reversible control of metastasis and age-associated disorders are novel functions of mtDNA, and suggests that ROS scavengers may be therapeutically effective to suppress these phenotypes.

摘要

线粒体 DNA 突变是否导致肿瘤发生以及转移的发展过程一直存在争议。为了阐明这个问题,我们建立了线粒体转移杂交细胞,这些细胞的线粒体 DNA 在具有高和低转移潜能的小鼠肿瘤细胞之间发生了交换。结果表明,来自高转移潜能肿瘤细胞的线粒体 DNA 中 ND6 基因的 G13997A 突变通过过量产生活性氧(ROS)可逆地控制转移的发展。具有 G13997A 线粒体 DNA 的线粒体转移模型小鼠表现出葡萄糖耐量受损的症状,表明产生 ROS 的线粒体 DNA 突变不仅可以调节转移潜能,还可以调节与年龄相关的疾病,如糖尿病。我们还鉴定了其他影响转移潜能的线粒体 DNA 突变,但这些机制与 ROS 的产生无关。线粒体 DNA 介导的转移和与年龄相关的疾病的可逆控制是线粒体 DNA 的新功能,并表明 ROS 清除剂可能具有治疗效果,以抑制这些表型。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验